BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 17979860)

  • 1. Repeat injection of botulinum toxin A is safe and effective for upper limb movement and function in children with cerebral palsy.
    Lowe K; Novak I; Cusick A
    Dev Med Child Neurol; 2007 Nov; 49(11):823-9. PubMed ID: 17979860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose/high-concentration localized botulinum toxin A improves upper limb movement and function in children with hemiplegic cerebral palsy.
    Lowe K; Novak I; Cusick A
    Dev Med Child Neurol; 2006 Mar; 48(3):170-5. PubMed ID: 16483391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional outcomes of intramuscular botulinum toxin type a and occupational therapy in the upper limbs of children with cerebral palsy: a randomized controlled trial.
    Wallen M; O'Flaherty SJ; Waugh MC
    Arch Phys Med Rehabil; 2007 Jan; 88(1):1-10. PubMed ID: 17207668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upper limb function after botulinum toxin A treatment in cerebral palsy: two years follow-up of six cases.
    Sätilä H; Kotamäki A; Koivikko M; Autti-Rämö I
    Pediatr Rehabil; 2006; 9(3):247-58. PubMed ID: 17050402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeat botulinum toxin-A injections in the upper limb of children with hemiplegia: a randomized controlled trial.
    Olesch CA; Greaves S; Imms C; Reid SM; Graham HK
    Dev Med Child Neurol; 2010 Jan; 52(1):79-86. PubMed ID: 19583742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
    Rameckers EA; Speth LA; Duysens J; Vles JS; Smits-Engelsman BC
    Neurorehabil Neural Repair; 2009; 23(3):218-25. PubMed ID: 19106252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper extremity function and occupational performance in children with spastic cerebral palsy following lower extremity botulinum toxin injections.
    Keren-Capelovitch T; Jarus T; Fattal-Valevski A
    J Child Neurol; 2010 Jun; 25(6):694-700. PubMed ID: 20508235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long lasting benefits following the combination of static night upper extremity splinting with botulinum toxin A injections in cerebral palsy children.
    Kanellopoulos AD; Mavrogenis AF; Mitsiokapa EA; Panagopoulos D; Skouteli H; Vrettos SG; Tzanos G; Papagelopoulos PJ
    Eur J Phys Rehabil Med; 2009 Dec; 45(4):501-6. PubMed ID: 20032908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial comparing botulinum toxin A dosage in the upper extremity of children with spasticity.
    Kawamura A; Campbell K; Lam-Damji S; Fehlings D
    Dev Med Child Neurol; 2007 May; 49(5):331-7. PubMed ID: 17489805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy.
    Fehlings D; Rang M; Glazier J; Steele C
    J Pediatr; 2000 Sep; 137(3):331-7. PubMed ID: 10969256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive therapy following upper limb botulinum toxin A injection in young children with unilateral cerebral palsy: a randomized trial.
    Hoare B; Imms C; Villanueva E; Rawicki HB; Matyas T; Carey L
    Dev Med Child Neurol; 2013 Mar; 55(3):238-47. PubMed ID: 23236956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
    Kaishou Xu ; Tiebin Yan ; Jianning Mai
    Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin, physical and occupational therapy, and neuromuscular electrical stimulation to treat spastic upper limb of children with cerebral palsy: a pilot study.
    Rodríguez-Reyes G; Alessi-Montero A; Díaz-Martínez L; Miranda-Duarte A; Pérez-Sanpablo AI
    Artif Organs; 2010 Mar; 34(3):230-4. PubMed ID: 20447049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
    Crowner BE; Racette BA
    Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upper-limb botulinum toxin A injection and occupational therapy in children with hemiplegic cerebral palsy identified from a population register: a single-blind, randomized, controlled trial.
    Russo RN; Crotty M; Miller MD; Murchland S; Flett P; Haan E
    Pediatrics; 2007 May; 119(5):e1149-58. PubMed ID: 17452491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy and tolerability of 4-monthly versus yearly botulinum toxin type A treatment for lower-limb spasticity in children with cerebral palsy.
    Kanovský P; Bares M; Severa S; Richardson A;
    Dev Med Child Neurol; 2009 Jun; 51(6):436-45. PubMed ID: 19563586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type A injection in alleviating postoperative pain and improving quality of life in lower extremity limb lengthening and deformity correction: a pilot study.
    Hamdy RC; Montpetit K; Raney EM; Aiona MD; Fillman RR; MacKenzie W; McCarthy J; Chafetz RS; Thomas SS; Tamayo CM; Littleton AG; Ruck-Gibis J; Takahashi SN; Rinaldi M; Finley GA; Platt RW; Dahan-Oliel N
    J Pediatr Orthop; 2009; 29(5):427-34. PubMed ID: 19568011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combined effect of lower-limb multilevel botulinum toxin type a and comprehensive rehabilitation on mobility in children with cerebral palsy: a randomized clinical trial.
    Scholtes VA; Dallmeijer AJ; Knol DL; Speth LA; Maathuis CG; Jongerius PH; Becher JG
    Arch Phys Med Rehabil; 2006 Dec; 87(12):1551-8. PubMed ID: 17141633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional outcome of botulinum toxin injection of gastrocnemius and adductors in spastic hemiplegic cerebral palsied children.
    Ibrahim AI; Hawamdeh ZM; Al-Qudah AA
    Eura Medicophys; 2007 Mar; 43(1):13-20. PubMed ID: 17021584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a multimodal management of prematurity-related spasticity.
    Papavasiliou AS; Rapidi CA; Filiopoulos C; Rizou C; Skouteli HN
    Pediatr Neurol; 2006 Dec; 35(6):400-7. PubMed ID: 17138009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.